Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combination of targeted agents in metastatic renal cell carcinoma: a path forward or a dead-end street?

× No keyword cloud information.

5 in total

Review 1. Sunitinib in the treatment of renal cell carcinoma: an update on recent evidence.

Authors: Mimma Rizzo; Camillo Porta
Journal: Ther Adv Urol Date: 2017-06-29

2. Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma.

Authors: Robert J Motzer; Bernard Escudier; Andrew Gannon; Robert A Figlin
Journal: Oncologist Date: 2016-11-02

3. A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.

Authors: B Rini; B Redman; J A Garcia; H A Burris; S Li; A Fandi; R Beck; U Jungnelius; J R Infante
Journal: Ann Oncol Date: 2014-06-08 Impact factor: 32.976

4. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.

Authors: Zheng Liu; Yidong Liu; Le Xu; Huimin An; Yuan Chang; Yuanfeng Yang; Weijuan Zhang; Jiejie Xu
Journal: Cancer Sci Date: 2015-07-29 Impact factor: 6.716

5. Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus.

Authors: Masahiro Matsuki; Yusuke Adachi; Yoichi Ozawa; Takayuki Kimura; Taisuke Hoshi; Kiyoshi Okamoto; Osamu Tohyama; Kaoru Mitsuhashi; Atsumi Yamaguchi; Junji Matsui; Yasuhiro Funahashi
Journal: Cancer Sci Date: 2017-04-20 Impact factor: 6.716

5 in total